Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-193540
Filing Date
2014-05-12
Accepted
2014-05-12 07:06:26
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d703385d10q.htm 10-Q 558941
2 EX-31.1 d703385dex311.htm EX-31.1 8713
3 EX-31.2 d703385dex312.htm EX-31.2 8720
4 EX-32.1 d703385dex321.htm EX-32.1 4409
  Complete submission text file 0001193125-14-193540.txt   5396973

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxdx-20140331.xml EX-101.INS 802339
6 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20140331.xsd EX-101.SCH 37727
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20140331_cal.xml EX-101.CAL 58932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20140331_def.xml EX-101.DEF 155797
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20140331_lab.xml EX-101.LAB 385762
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20140331_pre.xml EX-101.PRE 286910
Mailing Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121
Business Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-36344 | Film No.: 14831176
SIC: 2834 Pharmaceutical Preparations